Skip to main content
SpringerLink
Log in

Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Administration of interferon as a single therapeutic regimen in cancer patients with various neoplasias has had only limited efficacy in ameliorating the negative clinical course of their disease. In the present study, we have evaluated the effect of recombinant human fibroblast (IFNβ) and immune (IFNγ) interferon, alone and in combination, on growth, differentiation and the expression of class I and II histocompatibility locus antigens (HLA) and melanoma-associated antigens on the human melanoma cell line H0-1. The effect of combinations of interferons on the antigenic profile of human melanoma cells displaying different organ colonization and spontaneous metastatic potential in athymic nude mice was also determined. H0-1 cells were more sensitive to the antiproliferative activity of IFNβ than to IFNγ and the combination of interferons resulted in a potentiation of growth suppression. The antiproliferative effect of both interferons was greater in later-passage than in earlier-passage H0-1 cells, possibly reflecting alterations in the evolving tumor cell population as a result of long-term in vitro propagation and/or the selective outgrowth of cells with an increased growth rate. The enhanced growth suppression observed in H0-1 cells treated with the combination of IFNβ plus IFNγ was not associated with a significant increase in the level of melanin, a marker of melanoma differentiation, above that observed with either interferon used alone. IFNβ and IFNγ differentially modulated the expression of class I and II HLA and melanoma-associated antigens in H0-1 cells and a series of melanoma cells with different organ colonization and metastatic potential, including MeWo, MeM 50-10, MeM 50-17, 3S5 and 70W. No consistent potentiation or antagonism in the expression of any specific antigen was observed in any of the melanoma cell lines exposed to the combination of interferons. The present study demonstrates that the combination of IFNβ plus IFNγ can potentiate growth suppression in H0-1 human melanoma cells and that this effect is not associated with an increase in differentiation or a potentiation in antigenic modulation. In addition, no direct correlation between the expression of any specific antigen or its modulation by IFNβ or IFNγ, alone or in combination, and organ colonization and metastatic potential in nude mice was observed in the different melanoma cell lines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahmed MA, Guarini L, Ferrone S, Fisher PB (1989) Induction of differentiation in human melanoma cells by the combination of different classes of interferons or interferon plus mezerein. Ann NY Acad Sci 567: 333

    Google Scholar 

  2. Ahmed MA, Nielsch U, Guarini L, Hermo H Jr, Fisher PB (1990) Modulation of differentiation: a potential mechanism by which interferons induce antitumor activity. In: Fisher PB (ed) Mechanisms of differentiation: II. Modulation of differentiation by exogenous agents. CRC Press, Boca Raton, pp. 1–56

    Google Scholar 

  3. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens — new tool for genetic analysis. Cell 14: 9

    Google Scholar 

  4. Clemens MJ, McNurlan MA (1985) Regulation of cell proliferation and differentiation by interferons. Biochem J 226: 345

    Google Scholar 

  5. Cornil I, Man S, Fernandez B, Kerbel RS (1989) Enhanced tumorigenicity, melanogenesis, and metastases of a human malignant melanoma after subdermal implantation in nude mice. J Natl Cancer Inst 81: 938

    Google Scholar 

  6. Czarniecki CW, Fennie CW, Powers PB, Estell DA (1984) Synergistic antiviral and antiproliferative activities ofEscherichia coli derived human alpha, beta and gamma interferons. J Virol 49: 490

    Google Scholar 

  7. Fetell MR, Housepian EM, Oster MW, Cote DN, Sisti MB, Marcus SG, Fisher PB (1990) Intratumor administration of beta-interferon in recurrent malignant gliomas: a phase I clinical and laboratory study. Cancer 65: 78

    Google Scholar 

  8. Fisher PB, Grant S (1985) Effects of interferon on differentiation of normal and tumor cells. Pharmacol Ther 27: 143

    Google Scholar 

  9. Fisher PB, Prignoli D, Hermo H Jr, Weinstein IB, Pestka S (1985) Effects of combined treatment with interferon and mezerein on melanogenesis and growth in human melanoma cells. J Interferon Res 5: 11

    Google Scholar 

  10. Fisher PB, Babiss LE, Miranda AF (1986) Measurement of the effects of interferons on cellular differentiation in murine and human melanoma cultures. Methods Enzymol 119: 611

    Google Scholar 

  11. Fisher PB, Hermo H Jr, Solowey WE, Dietrich MC, Edwalds GM, Weinstein IB, Langer JA, Pestka S, Giacomini P, Kusama M, Ferrone S (1986) Effect of recombinant human fibroblast interferon and mezerein on growth, differentation, immune interferon binding and tumor associated antigen expression in human melanoma cells. Anticancer Res 6: 765

    Google Scholar 

  12. Friedman RL, Stark GR (1985) α-Interferon induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 314: 637

    Google Scholar 

  13. Giacomini P, Veglia F, Cordiali C, Fei P, Rehle T, Natali PG, Ferrone S (1984) Level of a membrane-bound high-molecularweight melanoma-associated antigen and of a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma. Cancer Res 44: 1281

    Google Scholar 

  14. Giacomini P, Fisher PB, Duigou GJ, Gambari R, Natali PG (1988) Regulation of class II MHC expression by interferons: insights into the mechanism of action of interferon (review). Anticancer Res 8: 1153

    Google Scholar 

  15. Giovanella BC, Stehlin JS, Santamaria C, Yim SO, Morgan AC, Williams LJ, Leibowitz A, Fialkow PY, Mumford DM (1976) Human neoplastic and normal cells in tissue culture. I. Cell lines derived from malignant melanomas and normal melanocytes. J Natl Cancer Inst 56: 1131

    Google Scholar 

  16. Goldstein D, Laszlo J (1986) Interferon therapy in cancer: from imagination to interferon. Cancer Res 46: 4315

    Google Scholar 

  17. Greiner JW, Schlom J, Pestka S, Langer JA, Giacomini P, Kusama M, Ferrone S, Fisher PB (1987) Modulation of tumor associated antigen expression and shedding by recombinant human leukocyte and fibroblast interferon. Pharmacol Ther 31: 209

    Google Scholar 

  18. Gresser I, Tovey M (1978) Antitumor effects of interferon. Biochim Biophys Acta 516: 231

    Google Scholar 

  19. Guadagni F, Kantor J, Schlom J, Greiner JW (1990) Regulation of tumor antigen expression by recombinant interferons. In: Fisher PB (ed) Mechanisms of differentiation: II. Modulation of differentiation by exogenous compounds. CRC Press, Boca Raton, pp. 57–80

    Google Scholar 

  20. Guarini L, Temponi M, Edwalds GM, Vita JR, Fisher PB, Ferrone S (1989) In vitro differentiation and antigenic changes in human melanoma cell lines. Cancer Immunol Immunother 30: 262

    Google Scholar 

  21. Guarini L, Temponi M, Bruce JN, Bollon AP, Duigou GJ, Moulton TA, Ferrone S, Fisher PB (1991) Expression and modulation by cytokines of the intercellular adhesion molecule-1 (ICAM-1) in human central nervous system tumor cell cultures. Int J Cancer (in press)

  22. Hannigan GE, Fish EN, Williams BRG (1984) Modulation of human interferon-α receptor expression by γ-interferon. J Biol Chem 259: 8084

    Google Scholar 

  23. Hubbell HR, Craft JA, Leibowitz PJ, Gillespie DH (1987) Synergistic antiproliferative effect of recombinant α-interferons with recombinant γ-interferon. J Biol Response Mod 6: 141

    Google Scholar 

  24. Imai K, Natali PG, Kay NE, Wilson BS, Ferrone S (1982) Tissue distribution and molecular profile of a differentiation antigen detected by a monoclonal antibody (345.134S) produced against human melanoma cells. Cancer Immunol Immunother 12: 159

    Google Scholar 

  25. Imai K, Wilson BS, Bigotti A, Natali PG, Ferrone S (1982) A 94,000-Dalton glycoprotein expressed by human melanoma and carcinoma cells. J Natl Cancer Inst 68: 761

    Google Scholar 

  26. Ishikawa M, Dennis JW, Man S, Kerbel RS (1988) Isolation and characterization of spontaneous wheat germ agglutinin-resistant human melanoma mutants displaying remarkably different metastatic profiles in nude mice. Cancer Res 48: 665

    Google Scholar 

  27. Johnson JD, Stade BG, Holzmann B, Schwable W, Riethmuller G (1989) De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86: 641

    Google Scholar 

  28. Kelly JM, Porter ACG, Chernajovsky Y, Gilbert CS, Stark GR, Kerr IM (1986) Characterization of a human gene inducible by α- and β-interferons and its expression in mouse cells. EMBO J 5: 1601–1606

    Google Scholar 

  29. Kerbel RS, Man MS (1984) Single-step selection of unique human melanoma variants displaying unusually aggressive metastatic behavior in nude athymic mice. Invasion Metastasis 4 (Suppl 1): 31

    Google Scholar 

  30. King H-F, Pan Y-CE, Moschera J, Tsai K, Bekesi F, Chang M, Sugino H, Honda S (1986) Purification of recombinant human immune interferon. Methods Enzymol 119: 204

    Google Scholar 

  31. Krown SE (1987) Clinical trials of interferons in human malignancy. In: Pfeffer LW (ed) Mechanisms of interferon actions, vol 2. CRC Press, Boca Raton, pp 143

    Google Scholar 

  32. Larner AC, Jonak G, Cheng Y-SE, Korant B, Knight E, Darnell JE (1984) Transcriptional induction of two genes by β interferon. Proc Natl Acad Sci USA 81: 6733

    Google Scholar 

  33. Leon JA, Mesa-Tejada R, Gutierrez MC, Estabrook A, Greiner JW, Schlom J, Fisher PB (1989) Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters. Anticancer Res 9: 1639

    Google Scholar 

  34. Maio M, Gulwani B, Tombesi S, Langer JA, Duigou GJ, Kerbel RS, Fisher PB, Ferrone S (1988) Differential induction by immune interferon of the gene products of the HLA-D region on the melanoma cell line MeWo and its metastatic variant MeM 50-10. J Immunol 141: 913

    Google Scholar 

  35. Maio M, Gulwani B, Langer JA, Kerbel RS, Duigou GJ, Fisher PB, Ferrone S (1989) Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Cancer Res 49: 2980

    Google Scholar 

  36. Mark DV, Lu SD, Creasey A, Yamamoto R, Lin L (1984) Site-specific mutagenesis of the human fibroblast interferon gene. Proc Natl Acad Sci USA 81: 5562

    Google Scholar 

  37. Matsui M, Temponi M, Ferrone S (1987) Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to modulation by immune interferon. J Immunol 139: 2088

    Google Scholar 

  38. Natali PG, Wilson BS, Imai K, Bigotti A, Ferrone S (1982) Tissue distribution, molecular profile and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells. Cancer Res 42: 583

    Google Scholar 

  39. Natali PG, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S (1990) Differential expression of intercellular adhesion molecule 1 (ICAM-1) in primary and metastatic melanoma lesions. Cancer Res 50: 1271

    Google Scholar 

  40. Oleszak E, Stewart WE II (1985) Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFNγ and HuIFNα or HuIFNβ. J Interferon Res 5: 361

    Google Scholar 

  41. Pellegrino MA, Ng AK, Russo C, Ferrone S (1982) Heterogeneous distribution of determinants defined by monoclonal antibodies on HLA-A and B antigen bearing molecules. Transplantation 34: 18

    Google Scholar 

  42. Pestka S, Langer JA, Zoon KC, Samuel CE (1987) Interferons and their actions. Annu Rev Biochem 56: 727

    Google Scholar 

  43. Pfeffer LM (ed) (1987) Mechanisms of interferon action, vol I, II. CRC Press, Boca Raton

    Google Scholar 

  44. Quaranta V, Pellegrino MA, Ferrone S (1981) Serological and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens. J Immunol 126: 548

    Google Scholar 

  45. Rehberg E, Kelder B, Hoal EG, Pestka S (1982) Specific molecular activities of recombinant and hybrid leukocyte interferons. J Biol Chem 257: 11497

    Google Scholar 

  46. Rossi GB (1985) Interferons and cell differentiation. In: Gresser I (ed) Interferon, vol 6. Academic Press, New York, p 31

    Google Scholar 

  47. Schiller JH, Groveman DS, Schmid SM, Willson JKV, Cummings KB, Borden EC (1986) Synergistic antiproliferative effects of human recombinant α54- or βser-interferon with γ-interferon on human cell lines of various histogenesis. Cancer Res 46: 483

    Google Scholar 

  48. Schiller JH, Bushmeyer SM, Ruzicka FJ, Princler GL, Faltynek CR, Borden EC (1990) Modulation of interferon receptor expression during combination βser-interferon and γ-interferon treatment of human colon carcinoma cells. Cancer Res 50: 26

    Google Scholar 

  49. Springer TA, Dustin ML, Takashi K, Kishimoto TK, Marlin SD (1987) The lymphocyte function-associated LFA-1, CD2 and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol 5: 223

    Google Scholar 

  50. Temponi M, Romano G, D'Urso CM, Wang Z, Kekish U, Ferrone S (1988) Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines. Semin Oncol 15: 595

    Google Scholar 

  51. Tsujisaki M, Igarashi M, Sakaguchi K, Eisinger M, Herlyn M, Ferrone S (1987) Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes. J Immunol 138: 1310

    Google Scholar 

  52. Vita JR, Edwalds GM, Gorey T, Housepian EM, Fetell MR, Guarini L, Langer JA, Fisher PB (1988) Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons. Anticancer Res 8: 297

    Google Scholar 

  53. Watson AJ, DeMars R, Trowbridge IS, Bach FH (1983) Detection of a novel human class II HLA antigen. Nature 304: 358

    Google Scholar 

  54. Wilson BS, Imai K, Natali PG, Ferrone S (1981) Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Intl J Cancer 28: 293

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Neurosurgery, Pathology and Urology, Columbia University, College of Physicians and Surgeons, 650 West 168th Street, 10 032, New York, NY, USA

    Gary M. Graham, Subashree Datta & Paul B. Fisher

  2. Division of Pediatric Hematology/Oncology, Comprehensive Cancer Center/Institute of Cancer Research, Columbia University, College of Physicians and Surgeons, 10 032, New York, New York, USA

    Ludovico Guarini & Thomas A. Moulton

  3. Department of Microbiology and Immunology, New York Medical College, 10 595, Valhalla, New York, USA

    Soldano Ferrone

  4. Immunology Laboratory, Regina Elena Institute, 00 161, Rome, Italy

    Patrizio Giacomini

  5. Division of Cancer and Cell Biology, Mt. Sinai Hospital Research Institute, M5G 1X5, Toronto, Ontario, Canada

    Robert S. Kerbel

Authors
  1. Gary M. Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ludovico Guarini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas A. Moulton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Subashree Datta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Soldano Ferrone
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Patrizio Giacomini
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robert S. Kerbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Paul B. Fisher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Graham, G.M., Guarini, L., Moulton, T.A. et al. Potentiation of growth suppression and modulation of the antigenic phenotype in human melanoma cells by the combination of recombinant human fibroblast and immune interferons. Cancer Immunol Immunother 32, 382–390 (1991). https://doi.org/10.1007/BF01741333

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01741333

Key words

Search

Navigation